Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/42708
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNoronha, Renata Maria de
dc.contributor.authorCalliari, Luis Eduardo Procopio [UNIFESP]
dc.contributor.authorDamaceno, Neiva
dc.contributor.authorMuramatu, Lucia Harumi
dc.contributor.authorMonte, Osmar
dc.date.accessioned2018-06-15T14:00:11Z-
dc.date.available2018-06-15T14:00:11Z-
dc.date.issued2011-11-01
dc.identifierhttp://dx.doi.org/10.1590/S0004-27302011000800016
dc.identifier.citationArquivos Brasileiros De Endocrinologia E Metabologia. Rio De Janeiro, Rj: Sbem-soc Brasil Endocrinologia & Metabologia, v. 55, n. 8, p. 613-621, 2011.
dc.identifier.issn0004-2730
dc.identifier.urihttp://repositorio.unifesp.br/11600/42708-
dc.description.abstractCystic fibrosis (CF) is the most common recessive autosomal disease among Caucasian. Children with CF have benefitted from advances in medical and nutritional treatments, and this can be gleaned from the improvement in the survival of these patients. The increase in the survival rate brought with it the appearance of co-morbidities related to CF. Nowadays cystic fibrosis-related diabetes (CFRD) is considered the most common complication associated with CF. It can appear as early as infancy or adolescence, and its prevalence can be as high as 50% in adult patients. Because of its high prevalence, difficulties in early detection and the risks involved, in recent years several studies and consensuses have focused on this condition, adding information about the epidemiology, pathophysiology, prognosis and treatment of CFRD. The main aspects of these new concepts, as well as the current recommendations for its diagnosis and follow-up, will be presented in this study. Arq Bras Endocrinol Metab. 2011;55(8):613-21en
dc.format.extent613-621
dc.language.isoeng
dc.publisherSbem-soc Brasil Endocrinologia & Metabologia
dc.relation.ispartofArquivos Brasileiros De Endocrinologia E Metabologia
dc.rightsAcesso aberto
dc.subjectDiabetes mellitusen
dc.subjectdiagnosticen
dc.subjectcystic fibrosisen
dc.subjectcystic fibrosis-related diabetesen
dc.subjectpathophysiologyen
dc.subjecttreatmenten
dc.titleUpdate on diagnosis and monitoring of cystic fibrosis-related diabetes mellitus (CFRD)en
dc.title.alternativeAtualização no diagnóstico e acompanhamento do diabetes melito relacionado à fibrose cística (DRFC)pt
dc.typeResenha
dc.contributor.institutionSanta Casa de Misericordia Sao Paulo
dc.contributor.institutionFCM SCSP
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionDept Clin Med
dc.description.affiliationSanta Casa de Misericordia Sao Paulo, Dept Pediat, Pediat Endocrinol Unit, BR-0122102 Sao Paulo, Brazil
dc.description.affiliationFCM SCSP, Sao Paulo, Brazil
dc.description.affiliationHosp Santa Casa Sao Paulo, Dept Pediat, Pediat Endocrinol Unit, Sao Paulo, Brazil
dc.description.affiliationHosp Santa Casa Sao Paulo, Dept Pediat, Pediat Pneumol Unit, Sao Paulo, Brazil
dc.description.affiliationDept Clin Med, Discipline Endocrinol, Sao Paulo, Brazil
dc.identifier.fileS0004-27302011000800016.pdf
dc.identifier.scieloS0004-27302011000800016
dc.identifier.doi10.1590/S0004-27302011000800016
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000298885900016
Appears in Collections:Resenha

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.